UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Cellectis is implementing good security practices.
Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy.
This report shows a preliminary security rating for Cellectis. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.Get a deeper scan →
Read more about the latest issues in cybersecurity
Digital forensics or digital forensic science is a branch of forensic science focused on the ...
Every week the news is full of new exposures of protected health information (PHI) and personally ...
Compare Cellectis's security performance with other companies